
Welcome
Admissions
Curriculum
Seminar Program
Research
Faculty
Staff & PostDocs
Students
Alumni & Friends
Medicinal Chemistry HOME
|

|
John C. Drach, Ph.D.
Professor, Department of Biologic and Materials Sciences, School of Dentistry
Professor of Medicinal Chemistry, College of Pharmacy
The University of Michigan School of Dentistry
Department of Biologic & Materials Sciences
Dental Building, RM 4222
1011 North University Avenue
Ann Arbor MI 48109-1078
Phone: (734) 763-5579
jcdrach@umich.edu
Education
John C. Drach, Ph. D. is Professor in the Department of Biologic and Materials Sciences at the
University of Michigan School of Dentistry. He also is a Professor of Medicinal Chemistry in the College of Pharmacy. Dr. Drach (or John) earned his Ph.D. in the Department of Biochemistry,
University of Cincinnati College of Medicine in 1966. He has been involved in antiviral drug research
since 1969 when was a Research Scientist at Parke-Davis and Company. His current research
interests are the design, discovery, metabolism, and mode of action of antiviral agents.
Research
Dr. Drach's research interests are the discovery, mode of action, and metabolism of antiviral drugs. The overall objective of his research group's work is to identify new compounds which have the potential to
become useful antiviral drugs and to investigate how promising compounds act at the cellular, molecular, and
biochemical level. Studies involve the discovery of new antiviral drugs by in vitro testing and biochemical
screening, investigation of the mode of action of new compounds, and how antivirals are metabolized in
uninfected and virus-infected mammalian cells. Viruses of interest include herpes simplex viruses types l and
2, human cytomegalovirus (HCMV), human herpes virus 6, and human immunodeficiency virus (HIV).
Current emphasis is on understanding the molecular basis for the activity of new compounds against HCMV
and HIV. Toward this end, his research group has derived by in vitro selection methods HCMV and HIV
strains which are resistant to active compounds. Such new viruses are characterized both phenotypically and
genotypically. Using drug resistance as a marker, his group is in the process of identifying and sequencing
HCMV and HIV genes that have mutated to give the drug resistant virus strains. Identification of such genes
is providing detailed understanding of antiviral drug action as well as fundamental knowledge on viral replication.
Questions/Comments
Rackham School of Graduate Studies | College of Pharmacy
page last modified: Friday, 15-Jan-1999 18:39:18 EST
©2001 University of Michigan
|